Levels of ADAM10 are reduced in Alzheimer’s disease CSF

被引：0
作者：
Aitana Sogorb-Esteve
María-Salud García-Ayllón
Johan Gobom
Jordi Alom
Henrik Zetterberg
Kaj Blennow
Javier Sáez-Valero
机构：
[1] Universidad Miguel Hernández-CSIC,Instituto de Neurociencias de Alicante
[2] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED),Servicio de Neurología, Hospital General Universitario de Elche
[3] Unidad de Investigación,Clinical Neurochemistry Laboratory
[4] Hospital General Universitario de Elche,Department of Neuroscience and Physiology
[5] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),Department of Molecular Neuroscience
[6] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),undefined
[7] Sahlgrenska University Hospital,undefined
[8] the Sahlgrenska Academy at the University of Gothenburg,undefined
[9] UCL Institute of Neurology,undefined
[10] UK Dementia Research Institute at UCL,undefined
来源：
Journal of Neuroinflammation | / 15卷
关键词：
Prodomain; Amyloid Precursor Protein (APP); ADAM10 Levels; ADAM10 Antibody; Ectodomain Antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Association between the characteristics of metabolic syndrome and Alzheimer's disease
    Yang, Hui-Ting
    Sheen, Yi-Jing
    Kao, Chuen-Der
    Chang, Chin-An
    Hu, Ya-Chun
    Lin, Jiann-Liang
    [J]. METABOLIC BRAIN DISEASE, 2013, 28 (04) : 597 - 604
  • [22] Familial Alzheimer's disease. Case-history
    Okacova, L
    Kanovsky, P
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 1995, 58 (06): : 294 - 296
  • [23] Association between the characteristics of metabolic syndrome and Alzheimer’s disease
    Hui-Ting Yang
    Yi-Jing Sheen
    Chuen-Der Kao
    Chin-An Chang
    Ya-Chun Hu
    Jiann-Liang Lin
    [J]. Metabolic Brain Disease, 2013, 28 : 597 - 604
  • [24] Biological markers of amyloid β-related mechanisms in Alzheimer's disease
    Hampel, Harald
    Shen, Yong
    Walsh, Dominic M.
    Aisen, Paul
    Shaw, Les M.
    Zetterberg, Henrik
    Trojanowski, John Q.
    Blennow, Kaj
    [J]. EXPERIMENTAL NEUROLOGY, 2010, 223 (02) : 334 - 346
  • [25] RAGE-Mediated Effects of Formaldehyde in Alzheimer’s Disease
    Ilya G. Mikhailov
    Milana S. Mikhailova
    Anton N. Shuvaev
    Yana V. Gorina
    Olga S. Belozor
    [J]. Biochemistry (Moscow), 2025, 90 (3) : 334 - 348
  • [26] Is anti-cholinesterase therapy of Alzheimer's disease delaying progression?
    Giacobini, E
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 13 (03) : 247 - 254
  • [27] Visualizing interaction of proteins relevant to Alzheimer's disease in intact cells
    Thomas, Anne V.
    Berezovska, Oksana
    Hyman, Bradley T.
    von Arnim, Christine A. F.
    [J]. METHODS, 2008, 44 (04) : 299 - 303
  • [28] Is anti-cholinesterase therapy of Alzheimer’s disease delaying progression?
    E. Giacobini
    [J]. Aging Clinical and Experimental Research, 2001, 13 : 247 - 254
  • [29] Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease
    Armstrong, Richard A.
    [J]. FOLIA NEUROPATHOLOGICA, 2011, 49 (03) : 153 - 161
  • [30] Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies
    Anitha, K.
    Singh, Mandeep Kumar
    Kohat, Komal
    Varshini, Sri T.
    Chenchula, Santenna
    Padmavathi, R.
    Amerneni, Lakshmi Sahitya
    Vardhan, Vishnu K.
    Bai, Mythili K.
    Chavan, Madhav Rao
    Bhatt, Shvetank
    [J]. MOLECULAR NEUROBIOLOGY, 2025, 62 (02) : 2314 - 2332
12345